BRPI0416564A - novas prostamidas para o tratamento de glaucoma e doenças relacionadas - Google Patents

novas prostamidas para o tratamento de glaucoma e doenças relacionadas

Info

Publication number
BRPI0416564A
BRPI0416564A BRPI0416564-0A BRPI0416564A BRPI0416564A BR PI0416564 A BRPI0416564 A BR PI0416564A BR PI0416564 A BRPI0416564 A BR PI0416564A BR PI0416564 A BRPI0416564 A BR PI0416564A
Authority
BR
Brazil
Prior art keywords
glaucoma
treatment
new
related diseases
prostamides
Prior art date
Application number
BRPI0416564-0A
Other languages
English (en)
Inventor
David F Woodward
Robert M Burk
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0416564A publication Critical patent/BRPI0416564A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"NOVAS PROSTAMIDAS PARA O TRATAMENTO DE GLAUCOMA E DOENçAS RELACIONADAS". A presente invenção refere-se a composições que compreendem uma amida relacionada a uma prostaglandina e uma amina em que a amina é selecionada do grupo que consiste de epinefrina, dopamina, serotonina e análogos e pró-drogas das mesmas. São também divulgados certos compostos químicos, composições farmacêuticas e processos de tratamento de glaucoma (Fórmula A).
BRPI0416564-0A 2003-11-13 2004-11-08 novas prostamidas para o tratamento de glaucoma e doenças relacionadas BRPI0416564A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/713,500 US7186744B2 (en) 2003-11-13 2003-11-13 Prostamides for the treatment of glaucoma and related diseases
PCT/US2004/037437 WO2005049558A1 (en) 2003-11-13 2004-11-08 Novel prostamides for the treatment of glaucoma and related diseases

Publications (1)

Publication Number Publication Date
BRPI0416564A true BRPI0416564A (pt) 2007-01-23

Family

ID=34573738

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416564-0A BRPI0416564A (pt) 2003-11-13 2004-11-08 novas prostamidas para o tratamento de glaucoma e doenças relacionadas

Country Status (7)

Country Link
US (2) US7186744B2 (pt)
EP (1) EP1682498A1 (pt)
JP (1) JP2007512252A (pt)
AU (1) AU2004291507A1 (pt)
BR (1) BRPI0416564A (pt)
CA (1) CA2546013A1 (pt)
WO (1) WO2005049558A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8673341B2 (en) * 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
WO2006041875A1 (en) * 2004-10-06 2006-04-20 Allergan, Inc. Novel prostamides for the treatment of glaucoma and related diseases
WO2007000641A2 (en) 2005-06-29 2007-01-04 Pfizer Inc. Prostaglandin derivatives
US7314890B2 (en) * 2005-08-22 2008-01-01 Allergan, Inc. Sulfonamides
US20090221703A1 (en) * 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
WO2008041054A1 (en) * 2006-10-02 2008-04-10 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
KR20210103586A (ko) 2007-06-04 2021-08-23 테크필즈 인크 매우 높은 피부 및 막 침투율을 가지는 비스테로이드성 소염제(ｎｓａｉａ) 약물전구체 및 이들의 새로운 의약적 용도
RU2630577C2 (ru) 2008-12-04 2017-09-11 Чунси ЮЙ Композиции интенсивного проникновения и их применение
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
CN116898848A (zh) 2012-01-18 2023-10-20 苏州泰飞尔医药有限公司 治疗肺部疾病的高穿透力前药组合物和医药组合物
US20210238124A1 (en) * 2018-04-20 2021-08-05 The General Hospital Corporation Acetylated prodrugs for delivery across the blood-brain barrier

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5013363A (pt) * 1973-06-08 1975-02-12
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
EP0286903B2 (en) * 1987-04-03 2000-03-29 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
ATE91419T1 (de) * 1990-05-22 1993-07-15 R Tech Ueno Ltd Synergistische kombination zur ophthalmischen verwendung.
US5688819A (en) 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6586462B2 (en) 2000-10-20 2003-07-01 Allergan, Inc. ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
US6376533B1 (en) 2000-10-20 2002-04-23 Allergan Sales, Inc. Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
US6410591B1 (en) 2001-05-08 2002-06-25 Allergan Sales, Inc. 3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
US6531504B2 (en) 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
US20030027853A1 (en) 2001-06-14 2003-02-06 Allergan Sales, Inc. 3, 7or3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
JP2005519879A (ja) 2001-12-03 2005-07-07 メルク　エンド　カムパニー　インコーポレーテッド Ｅｐ４受容体作動剤とその組成物および方法

Also Published As

Publication number Publication date
EP1682498A1 (en) 2006-07-26
JP2007512252A (ja) 2007-05-17
US20070112058A1 (en) 2007-05-17
CA2546013A1 (en) 2005-06-02
WO2005049558A1 (en) 2005-06-02
US7186744B2 (en) 2007-03-06
US20050107463A1 (en) 2005-05-19
AU2004291507A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
BRPI0416564A (pt) novas prostamidas para o tratamento de glaucoma e doenças relacionadas
BRPI0409227B8 (pt) "composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)"
BR0311494A (pt) Novos indóis substituìdos
BRPI0409109A (pt) novos compostos
BR0312729A (pt) Novos derivados de indol-3-enxofre
BR112016002496B1 (pt) Composto e composição farmacêutica
BRPI0410711A (pt) novos compostos
PE20040164A1 (es) Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas
EP1496892A4 (en) 1H-BENZO (F) INDAZOL-5-YL DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
CY1113873T1 (el) Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90
MA29629B1 (fr) Inhibiteurs de l'histone deacetylase
CA2941716A1 (en) Inhibitors of histone lysine specific demethylase (lsd1) and histone deacetylases (hdacs)
BRPI0415657A (pt) derivados de alcanamina de diidrobenzofuranila como agonistas de 5ht2c
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
CY1107956T1 (el) Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον
DOP2004000888A (es) 2-hidroxi-3-diaminoalcanos de benzamida (benzamide 2-hydroxy-3-diaminoalkanes
BRPI0513433A (pt) derivados de hidantoìna para o tratamento de distúrbios inflamatórios
DK1694318T3 (da) (S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum
MX2016007056A (es) Metodos para preparar compuestos de benzoquinolina.
AR041297A1 (es) Derivados de 4-pirrolidino- fenil- bencil eter
SV2009003295A (es) Derivados de aril sulfamida y metodos para su uso
BRPI0508724A (pt) derivados do fenilaminoetanol como agonistas do receptor beta2
ME01595B (me) Benzamidinska jedinjenja koja su korisna kao inhibitori histonske deacetilaze
AR048973A1 (es) (4-metoxi-7-morfolin-4-il-benzotiazol-2-il)amida del acido 4-hidroxi-4-metil-piperidin-1-carboxilico. proceso de preparacion y composiciones farmaceuticas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.